Antiviral Drug Strategies (Methods and Principles in Medicinal Chemistry) - nuovo libro

EAN (ISBN-13): 9783527326969
ISBN (ISBN-10): 3527326960
Copertina rigida
Anno di pubblicazione: 2011
Editore: Wiley-VCH
406 Pagine
Peso: 0,946 kg
Lingua: eng/Englisch

Libro nella banca dati dal 2008-06-20T09:28:49+02:00 (Rome)
Pagina di dettaglio ultima modifica in 2023-01-27T22:40:15+01:00 (Rome)
ISBN/EAN: 9783527326969

ISBN - Stili di scrittura alternativi:
3-527-32696-0, 978-3-527-32696-9
Stili di scrittura alternativi e concetti di ricerca simili:
Autore del libro : clercq, kubinyi, clerc, hugo, wiley vch, gerd folkers
Titolo del libro: principles chemistry

---

Dati dell'editore

Autore: Erik De Clercq
Titolo: Methods and Principles in Medicinal Chemistry; Antiviral Drug Strategies
Editore: Wiley-VCH; Wiley-VCH
406 Pagine
Anno di pubblicazione: 2011-04-06
Stampato / Fatto in
Peso: 0,970 kg
Lingua: Inglese
195,00 € (DE)
Not available (reason unspecified)
170mm x 240mm x 26mm

BB; Hardcover, Softcover / Chemie; Medizinische Chemie, Pharmazeutische Chemie; Verstehen; Chemie; Biowissenschaften; Chemie; Chemistry; Drug Discovery & Development; Life Sciences; Virologie; Virology; Wirkstoffforschung; Wirkstoffforschung u. -entwicklung; Wirkstoffforschung u. -entwicklung; Virologie

New viruses can arise very quickly and, if unchecked, result in major pandemics. Obvious examples being the AIDS and SARS virus. In order to deal with such imminent threats, drug development times need to be cut short. This is only possible by relying on proven strategies and adapting them to the specific features of any new virus or virus variant. By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics and to target new viruses. It is edited by Erik de Clercq, a world authority on antiviral drug discovery. The volume covers a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases, and primases, as well as their known inhibitors. The book also contains several case studies of recent successful antiviral drug development. As a result, medicinal and pharmaceutical chemists, as well as virologists will be able to pinpoint strategies for combating future viral pandemics.